CAS 81569-44-0
:Methyl 4-methylthiazole-5-carboxylate
Description:
Methyl 4-methylthiazole-5-carboxylate is an organic compound characterized by its thiazole ring, which is a five-membered heterocyclic structure containing sulfur and nitrogen. This compound features a methyl group and a carboxylate functional group, contributing to its reactivity and solubility properties. It is typically a colorless to pale yellow liquid or solid, depending on its purity and form. The presence of the carboxylate group suggests that it can participate in various chemical reactions, such as esterification and nucleophilic substitutions. Methyl 4-methylthiazole-5-carboxylate is often used in synthetic organic chemistry, particularly in the development of pharmaceuticals and agrochemicals, due to its potential biological activity. Additionally, it may exhibit specific odor characteristics, which can be relevant in flavor and fragrance applications. Safety data should be consulted for handling and storage, as with any chemical substance, to ensure proper precautions are taken.
Formula:C6H7NO2S
Synonyms:- Methyl 4-methyl-5-thiazolecarboxylate
- Methyl 4-methyl-5-thiazolyl formate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Methyl 4-methylthiazole-5-carboxylate
CAS:Formula:C6H7NO2SPurity:96%Color and Shape:SolidMolecular weight:157.1903Methyl 4-methylthiazole-5-carboxylate
CAS:<p>Methyl 4-methylthiazole-5-carboxylate</p>Purity:98%Molecular weight:157.19g/molMethyl 4-methylthiazole-5-carboxylate
CAS:Formula:C6H7NO2SPurity:96%Color and Shape:SolidMolecular weight:157.19Methyl 4-methylthiazole-5-carboxylate
CAS:<p>Methyl 4-methylthiazole-5-carboxylate (MTMC) is a compound with high chemical and biological activity. MTMC has been shown to inhibit the growth of S. aureus, and also exhibits cytotoxic effects on human cancer A549 cells in vitro. MTMC has been shown to be active against HIV in cell culture and also inhibits the replication of influenza virus. MTMC has significant activity against cancer, and is also effective against immunodeficiencies that are due to viral infection. It can be synthesized by a high-yielding process involving the reaction of methyl 4-nitrobenzoate with thiourea in an organic solvent under reflux conditions. The crystal structure of MTMC was determined by X-ray diffraction methods, revealing that it is centrosymmetric with four molecules present in the asymmetric unit.</p>Purity:Min. 95%



